Xpectra 300mg ER Tablet ER contains Faropenem, a broad-spectrum oral carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria. Indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections, Xpectra 300mg ER provides extended-release formulation to ensure sustained therapeutic levels, enhancing patient compliance through reduced dosing frequency. Faropenem acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exhibiting potent bactericidal activity. It is particularly useful in infections caused by beta-lactamase producing organisms due to its stability against many beta-lactamases. The extended-release formulation allows for a gradual release of the active ingredient, maintaining effective plasma concentration over an extended period. Xpectra 300mg ER should be administered as prescribed, typically once or twice daily depending on the severity and type of infection. Caution is advised in patients with a history of hypersensitivity to beta-lactam antibiotics. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Use during pregnancy and lactation should be under medical supervision. Proper diagnosis and susceptibility testing are recommended prior to initiation of therapy to ensure optimal clinical outcomes.